FEMME FiT CLA80 Femme 1000 mg product packaging

Image: NIH Office of Dietary Supplements, Dietary Supplement Label DatabaseNo separate image reuse license stated

FEMME FiT

CLA80 Femme 1000 mg

Softgel Capsule

Serving size4 Softgel(s)
Servings per containerNot listed
Package60 Softgel(s)
Data retrievedJul 28, 2026

Checking your goal…

Checking with your list…

1 labeled serving/day preview
Open the complete check →

Supplement Facts

Serving size 4 Softgel(s)

CLA80 Femme1000 mgDV not established
Conjugated Linoleic Acid800 mgDV not established

Other ingredients

Bovine Gelatin; Glycerin; Water; Purified; Vitamin E

Label directions

Directions: Take 4 softgels daily with food.

Label warnings

Prop 65 Warnings: Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner if you have a pre-existing medical condition including but not limited to cardiovascular disease (CVD) risk factors (e.g. high blood pressure high cholesterol and/or triglycerides). Do not use if you have CVD diabetes metabolic syndrome or insulin resistance. Some people may experience gastrointestinal upset. Keep out of reach of children. Do not use if inner seal is broken. California warning: lead is known to the State of California to cause birth defects or reproductive harm. Consuming this product can expose you to more than 0.0000005 g of lead. For more information go to www.P65Warnings.ca.gov. Allergen warning: Produced in a facility that also handles milk soy egg peanut tree nuts sesame fish crustacean and shellfish products.

Identity and label version

NIH label record326021
Entered into NIH DSLDMar 25, 2025
UPC / GTIN00665553200347
Manufacturer / distributor on labelHBS International Corp.
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.

NIH label history (1)

Current labelNIH record 326021Entered Mar 25, 2025
Serving size4 Softgel(s)
Formula versiona82aadae
Ingredients on label2
NIH sourceOpen label ↗
CLA80 Femme1000 mg
Conjugated Linoleic Acid800 mg

Label warning: Prop 65 Warnings: Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner if you have a pre-existing medical condition including but not limited to cardiovascular disease (CVD) risk factors (e.g. high blood pressure high cholesterol and/or triglycerides). Do not use if you have CVD diabetes metabolic syndrome or insulin resistance. Some people may experience gastrointestinal upset. Keep out of reach of children. Do not use if inner seal is broken. California warning: lead is known to the State of California to cause birth defects or reproductive harm. Consuming this product can expose you to more than 0.0000005 g of lead. For more information go to www.P65Warnings.ca.gov. Allergen warning: Produced in a facility that also handles milk soy egg peanut tree nuts sesame fish crustacean and shellfish products.

Sources and traceability

  • NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026
    Open source ↗

More from FEMME FiT

Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.